Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease

Gut

Volumn 67, Issue 1, 2018, Pages 108-119

  Imhann, Floris ^a   Vich Vila, Arnau ^a   Bonder, Marc Jan ^a   Fu, Jingyuan ^a   Gevers, DIrk ^b   Visschedijk, Marijn C ^a   Spekhorst, Lieke M ^a   Alberts, Rudi ^a   Franke, Lude ^a   Van Dullemen, Hendrik M ^a   Ter Steege, Rinze W F ^a   Huttenhower, Curtis ^b,d   DIjkstra, Gerard ^a   Xavier, Ramnik J ^b,c   Festen, Eleonora A M ^a   Wijmenga, Cisca ^a   Zhernakova, Alexandra ^a   Weersma, Rinse K ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

BACTERIAL INTERACTIONS; GENETICS; INFLAMMATORY BOWEL DISEASE; INTESTINAL BACTERIA

Indexed keywords

BACTERIAL RNA; RIBOSOME RNA;

ADULT; ARTICLE; ATG16L1 GENE; BACTERIAL GENE; BLOOD SAMPLING; CARD9 GENE; CASE CONTROL STUDY; CLINICAL FEATURE; COHORT ANALYSIS; COLON CROHN DISEASE; CONTROLLED STUDY; DISEASE COURSE; FECES ANALYSIS; FEMALE; FUT2 GENE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOME; GENOTYPE; GRAM POSITIVE BACTERIUM; HUMAN; ILEAL CROHN DISEASE; ILEUM DISEASE; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; IRGM GENE; MAJOR CLINICAL STUDY; MALE; MICROBIAL DIVERSITY; NOD2 GENE; ORGANISMAL INTERACTION; PHENOTYPE; PRIORITY JOURNAL; ROSEBURIA; SPECIES COMPOSITION; COMPLICATION; CROHN DISEASE; DYSBIOSIS; FECES; GENETIC PREDISPOSITION; GENETICS; HOST PATHOGEN INTERACTION; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PROCEDURES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; ULCERATIVE COLITIS;

ADULT; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; DYSBIOSIS; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; GENETIC PREDISPOSITION TO DISEASE; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 84991759922     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2016-312135     Document Type: Article

References (47)

1. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009;361:2066-78.
2. Ordás I, Eckmann L, Talamini M, et al. Ulcerative colitis. Lancet 2012;380:1606-19.
3. Liu JZ, van Sommeren S, Huang H, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet 2015;47:979-86.
4. Cleynen I, Boucher G, Jostins L, et al. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study. Lancet 2015;6736:1-12.
5. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012;491:119-24.
6. Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol 2015;12:205-17.
7. Jost T, Lacroix C, Braegger CP, et al. Vertical mother-neonate transfer of maternal gut bacteria via breastfeeding. Environ Microbiol 2014;16:2891-904.
8. Thaiss CA, Zeevi D, Levy M, et al. Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell 2014;159:514-29.
9. David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014;505:559-63.
10. Gevers D, Kugathasan S, Denson LA, et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 2014;15:382-92.
11. Tigchelaar EF, Bonder MJ, Jankipersadsing SA, et al. Gut microbiota composition associated with stool consistency. Gut 2016;65:540-2.
12. Dupont HL. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets. Aliment Pharmacol Ther 2014;39:1033-42.
13. Chung CS, Chang PF, Liao CH, et al. Differences of microbiota in small bowel and faeces between irritable bowel syndrome patients and healthy subjects. Scand J Gastroenterol 2016;51:410-19.
14. Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel diseases: current status and the future ahead. Gastroenterology 2014;146:1489-99.
15. Morgan XC, Tickle TL, Sokol H, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 2012;13:R79.
16. Blekhman R, Goodrich JK, Huang K, et al. Host genetic variation impacts microbiome composition across human body sites. Genome Biol 2015;16:191.
17. Goodrich JK, Waters JL, Poole AC, et al. Human genetics shape the gut microbiome. Cell 2014;159:789-99.
18. Brestoff JR, Artis D. Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol 2013;14:676-84.
19. Leamy LJ, Kelly SA, Nietfeldt J, et al. Host genetics and diet, but not immunoglobulin A expression, converge to shape compositional features of the gut microbiome in an advanced intercross population of mice. Genome Biol 2014;15:552.
20. Willing BP, Dicksved J, Halfvarson J, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010;139:1844-54. e1.
21. Joossens M, Huys G, Cnockaert M, et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 2011;60:631-7.
22. Hedin CR, McCarthy NE, Louis P, et al. Altered intestinal microbiota and blood T cell phenotype are shared by patients with Crohn's disease and their unaffected siblings. Gut 2014;63:1578-86.
23. Knights D, Silverberg MS, Weersma RK, et al. Complex host genetics influence the microbiome in inflammatory bowel disease. Genome Med 2014;6:107.
24. Tigchelaar EF, Zhernakova A, Dekens JA, et al. Cohort profile: LifeLines DEEP, a prospective, general population cohort study in the northern Netherlands: study design and baseline characteristics. BMJ Open 2015;5:e006772.
25. Festen EA, Stokkers PC, van Diemen CC, et al. Genetic analysis in a Dutch study sample identifies more ulcerative colitis susceptibility loci and shows their additive role in disease risk. Am J Gastroenterol 2010;105:395-402.
26. Shah TS, Liu JZ, Floyd JAB, et al. optiCall: a robust genotype-calling algorithm for rare, low-frequency and common variants. Bioinformatics 2012;28:1598-603.
27. Browning BL, Yu Z. Simultaneous genotype calling and haplotype phasing improves genotype accuracy and reduces false-positive associations for genome-wide association studies. Am J Hum Genet 2009;85:847-61.
28. Jia X, Han B, Onengut-Gumuscu S, et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS ONE 2013;8:e64683.
29. Rivas MA, Beaudoin M, Gardet A, et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 2011;43:1066-73.
30. Sokol H, Conway KL, Zhang M, et al. Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice. Gastroenterology 2013;145:591-601. e3.
31. Rausch P, Rehman A, Künzel S, et al. Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype. Proc Natl Acad Sci USA 2011;108:19030-5.
32. McCarroll SA, Huett A, Kuballa P, et al. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn ' s disease. Nat Genet 2008;40:1107-12.
33. Sadaghian Sadabad M, Regeling A, de Goffau MC, et al. The ATG16L1-T300A allele impairs clearance of pathosymbionts in the inflamed ileal mucosa of Crohn's disease patients. Gut 2015;64:1546-52.
34. Goyette P, Boucher G, Mallon D, et al. High-density mapping of the MHC identifies a shared role for HLA-DRB101:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat Genet 2015;47:172-9.
35. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010;7:335-6.
36. Ley RE. The Gene-Microbe Link. Nature 2015;518:S7.
37. Velasquez-Manoff M. Gut microbiome: the peacekeepers. Nature 2015;518:S3-11.
38. Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013;504:446-50.
39. Atarashi K, Tanoue T, Oshima K, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013;500:232-6.
40. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464:59-65.
41. Van den Abbeele P, Belzer C, Goossens M, et al. Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. ISME J 2013;7:949-61.
42. Ramanan D, Tang MS, Bowcutt R, et al. Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal bacteroides vulgatus. Immunity 2014;41:311-24.
43. Hansen JJ, Huang Y, Peterson DA, et al. The colitis-associated transcriptional profile of commensal Bacteroides thetaiotaomicron enhances adaptive immune responses to a bacterial antigen. PLoS ONE 2012;7:1-10.
44. Wu S, Zhang YG, Lu R, et al. Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis. Gut 2015;64:1082-94.
45. Imhann F, Bonder MJ, Vich Vila A, et al. Proton pump inhibitors affect the gut microbiome. Gut 2016;65:740-8.
46. Lewis JD, Chen EZ, Baldassano RN, et al. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn's disease. Cell Host Microbe 2015;18:489-500.
47. Averboukh F, Ziv Y, Kariv Y, et al. Colorectal carcinoma in inflammatory bowel disease: a comparison between Crohn's and ulcerative colitis. Color Dis 2011;13:1230-5.